NIH Schedules Closed Grant Review Meetings
Published Date: 6/18/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide funding for health research projects. Scientists and researchers applying for grants should note these dates as they impact which projects get money.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
NIH Grant Panels Meet Virtually in July
The NIH Center for Scientific Review will hold several closed virtual meetings on July 14, July 15, and July 16, 2026 to review and evaluate grant applications for multiple panels (for example: High Priority HIV and Substance Use Research; Pathobiology of Kidney Disease; Neurobiology; Nutrition, Diet, Obesity and Diabetes; and others). These meetings are where decisions are made about which research projects receive NIH funding.
Meetings Closed to Protect IP and Privacy
These NIH review meetings are closed to the public under sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., and pursuant to section 1009 of the Federal Advisory Committee Act, to protect confidential trade secrets, patentable material, and personal information in grant applications. If you apply for NIH funding, your trade secrets and personal data are formally protected during these reviews.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-19156, Proposed Collection; 60-Day Comment Request; Post-Award Reporting Requirements Including Research Performance Progress Report (OD)
The National Institutes of Health (NIH) wants your thoughts on updating how researchers report their progress after getting awards. This affects anyone who receives NIH funding and aims to make reporting clearer and less of a hassle. Comments are due by November 17, 2026, so don’t miss your chance to weigh in!
2026-19155, Proposed Collection; 60-Day Comment Request; PHS Applications and Pre-Award Reporting Requirements (OD)
The NIH is updating how researchers submit their Public Health Service applications and reports before awards, starting May 25, 2026. This change aims to make data management clearer and easier, affecting anyone applying for NIH funding. They want your feedback by November 17, 2026, to help improve the process without adding extra hassle or costs.
2026-18937, Proposed Collection; 60-Day Comment Request; NIH Intramural Reporting of Research Misconduct (IRRM) Web Form (Office of the Director/Office of Intramural Research)
The NIH is rolling out a new online form to make reporting research cheating easier and fairer. Anyone involved with NIH research can use this form to report problems like lying or copying, even anonymously. They want your feedback by November 16, 2026, to make sure the form works well without causing extra hassle.
2026-18877, Prospective Grant of an Exclusive Patent License: Development and Commercialization of Engineered Cell Therapies for the Treatment of HPV 16 E6-Expressing Cancers
The National Cancer Institute plans to give MedGene Therapeutics an exclusive license to develop and sell special engineered cell treatments for cancers caused by HPV 16 E6. This means MedGene will have the sole right to use these inventions, potentially speeding up new cancer therapies. If you want to comment or apply for a license, you must do so by September 30, 2026.
2026-18646, Draft NIH Biosafety Policy for Research Involving Biohazards
The NIH is updating its biosafety rules to keep research safe as science changes and grows. This new policy will replace old guidelines and affect anyone working with biohazards in NIH-funded research. They want your thoughts by October 19, 2026, to help shape these important safety updates without adding extra costs.
2026-18191, Submission for OMB Review; 30-Day Comment Request Data and Specimen Hub (DASH) (Eunice Kennedy Shriver National Institute of Child Health and Human Development)
The National Institutes of Health (NIH) is asking for public feedback on their Data and Specimen Hub (DASH), which helps researchers share important health data. This is a quick 30-day review to make sure the information collection is clear and useful. If you’re involved in health research or data sharing, your input by October 8, 2026, can help shape how DASH works without costing extra money or time.
Previous / Next Documents
Previous: 2026-12243, Notice of Request for Revision to and Extension of Approval of an Information Collection; African Swine Fever; Importation of Live Dogs for Resale From Regions Where ASF Exists or Is Reasonably Believed To Exist
The USDA is updating and extending rules about importing live dogs for resale from places where African Swine Fever (ASF) is known or suspected. This affects dog importers who must provide updated info to help keep ASF out of the U.S. You’ve got until August 17, 2026, to share your thoughts, and these changes aim to keep things safe without adding big costs.
Next: 2026-12245, Authorization of Emergency Use for Two Animal Drugs for the Prevention and Treatment of New World Screwworm; Availability
The FDA just gave the green light for two new animal drugs to fight the nasty New World screwworm, a bug that harms cattle, horses, pigs, and even exotic animals. These emergency approvals started in April 2026 to help protect U.S. livestock and wildlife quickly. Farmers, vets, and animal lovers can now use these treatments to stop infestations and keep animals safe without delay.